European Union Recommended NAION Warnings In June 2025, the European Medicines Agency (EMA) recommended updating the labeling for semaglutide to list NAION as a very rare side effect, affecting up to 1 in 10,000 users
In the central nervous system, proglucagon and proglucagon-derived peptides (GLP-1, glucagon-like peptide-2, GLP-2, and oxyntomodulin, OXM) are only present in a small group of neurons in the nucleus tractus solitarius (24, 25)
They may work synergistically to enhance antioxidant support and overall wellness
Compounded semaglutide is chemically identical to brand-name versions but available at a fraction of the cost ($189/mo vs
True fat loss acceleration typically becomes evident by weeks 34 as sustained caloric deficit accumulates
If theres a shortage, compounding gets more leeway